Video

3 Actions the DEA May Take if a Pharmacy Is Found to Be Out of Compliance

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.

This video was recorded at the 2015 NCPA Annual Convention.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Phone call, pharmacist woman and writing on medicine checklist, customer service or virtual pharmacy support. Serious doctor with medical notes, health insurance documents and talking at help desk
Related Content
Eye scan showing macular degeneration -- Image credit: Rabizo Anatolii | stock.adobe.com
September 6th 2025

Efficacy, Safety, and Immunogenicity Maintained When Patients With nAMD Switch from Eylea to Biosimilar

Gillian McGovern, Associate Editor
Pharmacy Focus Oncology Edition Podcast
September 6th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
FDA approves risperidone extended-release suspension for schizophrenia -- Image credit: wladimir1804 | stock.adobe.com
September 6th 2025

Amneal’s Injectable Extended-Release Suspension of Risperidone Receives FDA Approval to Treat Schizophrenia

Gillian McGovern, Associate Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 6th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Small drug vial with influenza vaccine | Image Credit: Leigh Prather | stock.adobe.com
September 6th 2025

High-Dose Influenza Vaccine Linked to Lower Risk of Myocarditis, Pericarditis in Older Adults

Danielle Valletti, Assistant Editor
Expert Q&A: How Orforglipron Could Transform Obesity Treatment
September 6th 2025

Expert Q&A: How Orforglipron Could Transform Obesity Treatment

Katherine H. Saunders, MD, DABOM Aislinn Antrim, Managing Editor
© 2025 MJH Life Sciences

All rights reserved.